{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:52:53Z","timestamp":1789487573546,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04287-y","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:42:23Z","timestamp":1789483343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine release syndrome in adults with acute leukemia after allo-HCT with posttransplant cyclophosphamide prophylaxis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-1444","authenticated-orcid":false,"given":"Nikita","family":"Volkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Botina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Zhogolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Beynarovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Ziganshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Siniaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Vlasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Rudakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Rogacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniia","family":"Afanaseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vladovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Bondarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kulagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"2","key":"4287_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u201395. https:\/\/doi.org\/10.1182\/blood-2014-05-552729.","journal-title":"Blood"},{"key":"4287_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.659419","volume":"12","author":"S Yuan","year":"2021","unstructured":"Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. Quantification of cytokine storms during virus infections. Front Immunol. 2021;12:659419. https:\/\/doi.org\/10.3389\/fimmu.2021.659419.","journal-title":"Front Immunol"},{"issue":"6","key":"4287_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","volume":"6","author":"DT Teachey","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, et al. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016;6(6):664\u201379. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0040.","journal-title":"Cancer Discov"},{"issue":"4","key":"4287_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625\u201338. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"4287_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.bbmt.2016.06.010","volume":"22","author":"R Abboud","year":"2016","unstructured":"Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, et al. Severe cytokine-release syndrome after T cell\u2013replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated. Biol Blood Marrow Transplant. 2016;22(10):1851\u201360. https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.010.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"4287_CR6","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41409-021-01403-w","volume":"56","author":"R Abboud","year":"2021","unstructured":"Abboud R, Wan F, Mariotti J, Arango M, Castagna L, Romee R, et al. Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplant. 2021;56(11):2763\u201370. https:\/\/doi.org\/10.1038\/s41409-021-01403-w.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"4287_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.bbmt.2020.06.006","volume":"26","author":"MB Abid","year":"2020","unstructured":"Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, et al. Severity of cytokine release syndrome and its association with infections after T cell-replete haploidentical related donor transplantation. Biol Blood Marrow Transplant. 2020;26(9):1670\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2020.06.006.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4287_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/cam4.2607","volume":"9","author":"J Mariotti","year":"2020","unstructured":"Mariotti J, Taurino D, Marino F, Bramanti S, Sarina B, Morabito L, et al. Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide. Cancer Med. 2020;9(1):52\u201361. https:\/\/doi.org\/10.1002\/cam4.2607.","journal-title":"Cancer Med"},{"issue":"12","key":"4287_CR9","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.bbmt.2019.07.027","volume":"25","author":"PH Imus","year":"2019","unstructured":"Imus PH, Blackford AL, Bettinotti M, Luznik L, Fuchs EJ, Huff CA, et al. Severe cytokine release syndrome after haploidentical peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2019;25(12):2431\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.027.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4287_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/16078454.2021.1978752","volume":"26","author":"Z Xu","year":"2021","unstructured":"Xu Z, Zhou X, Zhao X, Lu X, Tang L, Shi W, et al. Cytokine release syndrome after haploidentical hematopoietic stem cell transplantation with antithymocyte globulin: risk factors analysis and poor impact on outcomes for non-remisssion patients. Hematology (United States). 2021;26(1):809\u201317. https:\/\/doi.org\/10.1080\/16078454.2021.1978752.","journal-title":"Hematology (United States)"},{"issue":"2","key":"4287_CR11","doi-asserted-by":"publisher","first-page":"111.e1","DOI":"10.1016\/j.jtct.2021.11.012","volume":"28","author":"S Otoukesh","year":"2022","unstructured":"Otoukesh S, Elmariah H, Yang D, Clark MC, Siraj M, Ali H, et al. Cytokine release syndrome following peripheral blood stem cell haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide. Transplant Cell Ther. 2022;28(2):111.e1-111.e8. https:\/\/doi.org\/10.1016\/j.jtct.2021.11.012.","journal-title":"Transplant Cell Ther"},{"issue":"15","key":"4287_CR12","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1182\/bloodadvances.2023009657","volume":"7","author":"RM Shapiro","year":"2023","unstructured":"Shapiro RM, Kim HT, Ansuinelli M, Guleria I, Cutler CS, Koreth J, et al. Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse. Blood Adv. 2023;7(15):4080\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2023009657.","journal-title":"Blood Adv"},{"issue":"4","key":"4287_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/hon.2772","volume":"38","author":"L Sol\u00e1n","year":"2020","unstructured":"Sol\u00e1n L, Landete E, Bail\u00e9n R, Dorado N, Oarbeascoa G, Anguita J, et al. Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide. Hematol Oncol. 2020;38(4):597\u2013603. https:\/\/doi.org\/10.1002\/hon.2772.","journal-title":"Hematol Oncol"},{"issue":"9","key":"4287_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1080\/10428194.2024.2344060","volume":"65","author":"PA von dem Borne","year":"2024","unstructured":"von dem Borne PA, Kemps-Mols BM, de Wreede LC, van Beek AA, Snijders TJF, van Lammeren D, et al. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leuk Lymphoma. 2024;65(9):1270\u201380. https:\/\/doi.org\/10.1080\/10428194.2024.2344060.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"4287_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41409-025-02594-2","volume":"60","author":"R Benavente","year":"2025","unstructured":"Benavente R, Montoro J, Balaguer-Rosell\u00f3 A, Villalba M, Chor\u00e3o P, Asensi P, et al. Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy. Bone Marrow Transplant. 2025;60(7):1020\u20136. https:\/\/doi.org\/10.1038\/s41409-025-02594-2.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"4287_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22(1):4\u201310. https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.001.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"4287_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2014","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2014;21(3):389\u2013401.e1. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"4287_CR18","first-page":"367","volume":"6","author":"KG Lerner","year":"1974","unstructured":"Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6(4):367\u201371.","journal-title":"Transplant Proc."},{"issue":"10","key":"4287_CR19","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.bbmt.2018.06.004","volume":"24","author":"SR McCurdy","year":"2018","unstructured":"McCurdy SR, Muth ST, Tsai HL, Symons HJ, Huff CA, Matsui WH, et al. Early fever after haploidentical bone marrow transplantation correlates with class II HLA-mismatching and myeloablation but not outcomes. Biol Blood Marrow Transplant. 2018;24(10):2056\u201364. https:\/\/doi.org\/10.1016\/j.bbmt.2018.06.004.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"4287_CR20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.bbmt.2018.04.010","volume":"24","author":"RV Raj","year":"2018","unstructured":"Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, et al. Peripheral blood grafts for T cell\u2013replete haploidentical transplantation increase the incidence and severity of cytokine release syndrome. Biol Blood Marrow Transplant. 2018;24(8):1664\u201370. https:\/\/doi.org\/10.1016\/j.bbmt.2018.04.010.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"4287_CR21","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1182\/blood-2006-07-034348","volume":"109","author":"RM Saliba","year":"2007","unstructured":"Saliba RM, De Lima M, Giralt S, Andersson B, Khouri IF, Hosing C, et al. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood. 2007;109(7):2751\u20138. https:\/\/doi.org\/10.1182\/blood-2006-07-034348.","journal-title":"Blood"},{"issue":"1","key":"4287_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/ijd.ijd_503_22","volume":"68","author":"GD Mahabal","year":"2023","unstructured":"Mahabal GD, George L, Peter D, Thomas M, George B, Mathews V, et al. Hyperacute graft-versus-host disease of the skin following allogeneic stem cell transplantation: a paediatric case series. Indian J Dermatol. 2023;68(1):73\u20137. https:\/\/doi.org\/10.4103\/ijd.ijd_503_22.","journal-title":"Indian J Dermatol"},{"key":"4287_CR23","volume-title":"The EBMT handbook: hematopoietic cell transplantation and cellular therapies","author":"E Holler","year":"2024","unstructured":"Holler E, Greinix H, Zeiser R. Acute graft-versus-host disease. In: Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E, editors. The EBMT handbook: hematopoietic cell transplantation and cellular therapies. 8th ed. Cham (CH): Springer; 2024.","edition":"8"},{"issue":"26","key":"4287_CR24","doi-asserted-by":"publisher","first-page":"00333","DOI":"10.1016\/j.jtct.2026.04.042","volume":"S2666\u20136367","author":"I Moiseev","year":"2026","unstructured":"Moiseev I, Drokov M, Kitaeva Y, Rudakova T, Barabanshchikova M, Chernyshova D, et al. A randomized, multicenter phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide. Transplant Cell Ther. 2026;S2666\u20136367(26):00333\u20137. https:\/\/doi.org\/10.1016\/j.jtct.2026.04.042.","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"4287_CR25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, Von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800\u201310. https:\/\/doi.org\/10.1056\/NEJMoa1917635.","journal-title":"N Engl J Med"},{"issue":"2","key":"4287_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jcmm.16176","volume":"25","author":"J Pan","year":"2021","unstructured":"Pan J, Deng B, Ling Z, Song W, Xu J, Duan J, et al. Ruxolitinib mitigates steroid\u2010refractory CRS during CAR T therapy. J Cell Mol Med. 2021;25(2):1089\u201399. https:\/\/doi.org\/10.1111\/jcmm.16176.","journal-title":"J Cell Mol Med"},{"key":"4287_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2022.01.070","volume":"595","author":"N Xu","year":"2022","unstructured":"Xu N, Yang XF, Xue SL, Tan JW, Li MH, Ye J, et al. Ruxolitinib reduces severe CRS response by suspending CAR-T cell function instead of damaging CAR-T cells. Biochem Biophys Res Commun. 2022;595:54\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.070.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"4287_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10215190","volume":"10","author":"THA Tvedt","year":"2021","unstructured":"Tvedt THA, Vo AK, Bruserud \u00d8, Reikvam H. Cytokine release syndrome in the immunotherapy of hematological malignancies: the biology behind and possible clinical consequences. J Clin Med. 2021;10(21):5190. https:\/\/doi.org\/10.3390\/jcm10215190.","journal-title":"J Clin Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04287-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:42:24Z","timestamp":1789483344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":28,"alternative-id":["4287"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04287-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the local Ethics Committee of the RM Gorbacheva Research Institute, Pavlov University.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study and the use of anonymized clinical data, the requirement for written informed consent was waived by the Ethics Committee.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}